Skip to content
Lab150
  • Home
  • About
    • About LAB150
    • Our Partners
    • Our Team
    • Steering Committee
    • TIAP Members
  • Work With Us
    • Our Process
    • FAQ
    • Submit
  • News
    • Events
  • Contact
  • LinkedIn
  • Twitter
Home
•
LAB150

Author: LAB150

Press Release

MaRS Innovation and Evotec AG Establish Academic Bridge “LAB150” In Toronto

Toronto, Sept. 14, 2017 (GLOBE NEWSWIRE) — MaRS Innovation (“MI”) and Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced the launch of “LAB150”.  This transformational Toronto-based partnership will give Canada access to the world-class infrastructure and drug discovery expertise of Evotec, and…

Read Morearrow_forward
September 14, 2017 by LAB150
Recent Posts
  • Webinar: Let’s Get Clinical – Anticipating Clinical Trials in Your Pre-Clinical Work
  • Webinar February 24, 2021 – Adventures in Drug Hunting: Identify and Advance Your Drug-Like Molecule
  • TIAP & Amgen co-fund transformative projects to support new venture development
  • Webinar: Staying on Target: Is your research program ready for drug discovery?
  • Project 7: Novel Therapeutic Agent for Immuno-Oncology from Sunnybrook Research Institute
  • LinkedIn
  • Twitter
2023 LAB150. All rights reserved. | Privacy Policy